FAK inhibition combined with the RAF/MEK clamp avutometinib overcomes resistance to BRAF and MEK inhibitors and to immune checkpoint blockade in BRAFV600E mutant cutaneous melanoma

FAK inhibition combined with the RAF/MEK clamp avutometinib overcomes resistance to BRAF and MEK inhibitors and to immune checkpoint blockade in BRAFV600E mutant cutaneous melanoma

FAK inhibition combined with the RAF/MEK clamp avutometinib research